Keyur P. Patel

25.5k citations

334 papers · 8.6k indexed · h-index 48

Hematology top 0.1%
Molecular Biology top 2%
Genetics top 0.2%
Oncology top 1%
Cancer Research top 0.5%

Co-authors: L. Jeffrey Medeiros Hagop M. Kantarjian Rajyalakshmi Luthra Mark J. Routbort Farhad Ravandi Jörge E. Cortes Guillermo Garcia‐Manero Bedia A. Barkoh
Topics: Acute Myeloid Leukemia Research (151 papers)Chronic Lymphocytic Leukemia Research (70 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (70 papers)
Cited by: Hematology Genetics Cancer Research
Journals: Proceedings of the National Academy of Sciences Journal of Clinical OncologySHILAP Revista de lepidopterología
Partner nations: United States Japan Canada

In The Last Decade

Keyur P. Patel

316 papers receiving 8.5k citations

Peers

Countries citing papers authored by Keyur P. Patel

Since Specialization

Citations

This map shows the geographic impact of Keyur P. Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keyur P. Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keyur P. Patel more than expected).

Fields of papers citing papers by Keyur P. Patel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keyur P. Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keyur P. Patel. The network helps show where Keyur P. Patel may publish in the future.

Co-authorship network of co-authors of Keyur P. Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Keyur P. Patel. A scholar is included among the top collaborators of Keyur P. Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keyur P. Patel. Keyur P. Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Routine Clinical Liquid Biopsy Testing for Solid Tumors Delivers the Promise of Minimally Invasive Detection of Genomic Variants With a Faster Turnaround Time 2025 ·JCO Precision Oncology ·(unknown),Richard K. Yang,Fatima Zahra Jelloul,Rajyalakshmi Luthra,Mark J. Routbort,Hui Chen,Sanam Loghavi,Chi Young Ok,Rashmi Kanagal‐Shamanna,Sinchita Roy‐Chowdhuri,L. Jeffrey Medeiros,Keyur P. Patel	2
2	Concordance between Tumor Tissue and Plasma DNA Genotyping in the NCI-MATCH Trial (EAY131) 2025 ·Clinical Cancer Research ·Mohamed A. Gouda,Filip Jankú,Ying Yuan,Leylah Drusbosky,Alice P. Chen,(unknown),Keyur P. Patel,Stanley R. Hamilton,Mark J. Routbort,James V. Tricoli,P. Mickey Williams,A. John Iafrate,Jeffrey Sklar,Brent Coffey,Richard F. Little,Carlos L. Arteaga,Peter J. O’Dwyer,Keith T. Flaherty,Lyndsay N. Harris,Funda Meric‐Bernstam	1
3	Gemtuzumab Ozogamicin Added to Fludarabine, Cytarabine and G-CSF (FLAG-GO) Leads to Superior Molecular Response and Survival Outcomes Than Idarubicin (FLAG-IDA): 200 Patients Long-Term Follow up 2024 ·Blood ·Jayastu Senapati,H. Kantarjian,Edward Ayoub,(unknown),Tapan M. Kadia,Courtney D. DiNardo,Naval Daver,Fadi Haddad,Naveen Pemmaraju,Nicholas J. Short,Maro Ohanian,Musa Yılmaz,Keyur P. Patel,(unknown),Sherry Pierce,Guillermo Garcia‐Manero,Farhad Ravandi,Gautam Borthakur	1
4	Circulating tumor DNA as a predictive biomarker for pathologic response after treatment with neoadjuvant immunotherapy for localized dMMR/MSI-H colorectal cancer. 2024 ·Journal of Clinical Oncology ·(unknown),F. Anthony San Lucas,(unknown),Keyur P. Patel,(unknown),Wai Chin Foo,Dipen M. Maru,Scott Kopetz,Kaysia Ludford,Van K. Morris,Michael J. Overman	0
5	Predictors of early and long-term readmissions and their association with survival after liver transplantation 2023 ·Narina Simonian,Mayur Brahmania,Mamatha Bhat,Anthony Kim,(unknown),(unknown),Keyur P. Patel	0
6	Limited Independent Follow-Up with Germline Testing of Variants Detected in BRCA1 and BRCA2 by Tumor-Only Sequencing 2023 ·SHILAP Revista de lepidopterología ·(unknown),Molly S. Daniels,(unknown),Ecaterina E. Dumbrava,Ying Yuan,Keyur P. Patel,(unknown),(unknown),Chetna Wathoo,(unknown),(unknown),Wanlin Wang,Chacha Horombe,Milind Javle,Jordi Rodón,Timothy A. Yap,Banu Arun,Karen H. Lu,Funda Meric‐Bernstam	1
7	A Five-Year Clinical Course of Potential Phenocopy Syndrome of Behavioral Variant Frontotemporal Dementia: A Case Report and Literature Review 2023 ·Cureus ·(unknown),Keyur P. Patel,(unknown)	1
8	Venetoclax abrogates the prognostic impact of splicing factor gene mutations in newly diagnosed acute myeloid leukemia 2023 ·Blood ·Jayastu Senapati,(unknown),Sanam Loghavi,Nicholas J. Short,Ghayas C. Issa,Abhishek Maiti,Hussein A. Abbas,Naval Daver,Naveen Pemmaraju,Sherry Pierce,Kelly S. Chien,Koji Sasaki,Tapan M. Kadia,Danielle Hammond,Gautam Borthakur,Keyur P. Patel,Farhad Ravandi,Hagop M. Kantarjian,Guillermo Garcia‐Manero,Courtney D. DiNardo	35
9	The outcomes of patients with chronic myeloid leukemia treated with third‐line BCR::ABL1 tyrosine kinase inhibitors 2023 ·American Journal of Hematology ·Elias Jabbour,Koji Sasaki,Fadi Haddad,Ghayas C. Issa,Guillermo Garcia‐Manero,Tapan M. Kadia,Nitin Jain,Musa Yılmaz,Courtney D. DiNardo,Keyur P. Patel,Rashmi Kanagal‐Shamanna,Richard Champlin,Issa F. Khouri,Sara Dellasala,Sherry Pierce,Hagop M. Kantarjian	15
10	Activity of decitabine as maintenance therapy in core binding factor acute myeloid leukemia 2022 ·American Journal of Hematology ·Jayastu Senapati,Mahran Shoukier,Guillermo Garcia‐Manero,Xuemei Wang,Keyur P. Patel,Tapan M. Kadia,Farhad Ravandi,Naveen Pemmaraju,Maro Ohanian,Naval Daver,Courtney D. DiNardo,Yesid Alvarado,(unknown),Gautam Borthakur	15
11	Retrospective comparison of survival and responses to Fludarabine, Cytarabine, GCSF (FLAG) in combination with gemtuzumab ozogamicin (GO) or Idarubicin (IDA) in patients with newly diagnosed core binding factor (CBF) acute myelogenous leukemia: MD Anderson experience in 174 patients 2022 ·American Journal of Hematology ·Gautam Borthakur,Farhad Ravandi,Keyur P. Patel,Xuemei Wang,Tapan M. Kadia,Courtney D. DiNardo,Guillermo Garcia‐Manero,Naveen Pemmaraju,Elias Jabbour,Koichi Takahashi,Maro Ohanian,Naval Daver,Yesid Alvarado,Mark Brandt,Sherry Pierce,Hagop M. Kantarjian	20
12	Prediction of survival with intensive chemotherapy in acute myeloid leukemia 2022 ·American Journal of Hematology ·Koji Sasaki,Farhad Ravandi,Tapan M. Kadia,Courtney D. DiNardo,Gautam Borthakur,Nicholas J. Short,Nitin Jain,Naval Daver,Elias Jabbour,Guillermo Garcia‐Manero,Joseph D. Khoury,Sergej Konoplev,Sanam Loghavi,Keyur P. Patel,Guillermo Montalban‐Bravo,Lucia Masárová,Marina Konopleva,Hagop M. Kantarjian	13
13	Outcome of patients with IDH1/2-mutated post–myeloproliferative neoplasm AML in the era of IDH inhibitors 2020 ·Blood Advances ·Helen T. Chifotides,Lucia Masárová,Mansour Alfayez,Naval Daver,Yesid Alvarado,Elias Jabbour,Marina Konopleva,Hagop M. Kantarjian,Keyur P. Patel,Courtney D. DiNardo,Srđan Verstovšek	37
14	Clonal evolution and treatment outcomes in hematopoietic neoplasms arising in patients with germline RUNX1 mutations 2020 ·American Journal of Hematology ·Curtis A. Lachowiez,Sarah A. Bannon,Sanam Loghavi,Feng Wang,Rashmi Kanagal‐Shamanna,Rohtesh S. Mehta,Naval Daver,Gautam Borthakur,Naveen Pemmaraju,Farhad Ravandi,Keyur P. Patel,Guillermo Garcia‐Manero,Koichi Takahashi,Hagop M. Kantarjian,Kapil N. Bhalla,Courtney D. DiNardo	3
15	DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high‐risk disease 2019 ·American Journal of Hematology ·Andres Quesada,Mark J. Routbort,Courtney D. DiNardo,Carlos E. Bueso‐Ramos,Rashmi Kanagal‐Shamanna,Joseph D. Khoury,Beenu Thakral,Zhuang Zuo,C. Cameron Yin,Sanam Loghavi,Chi Young Ok,Sa A. Wang,Zhenya Tang,Sarah A. Bannon,Christopher B. Benton,Guillermo Garcia‐Manero,Hagop M. Kantarjian,Rajyalakshmi Luthra,L. Jeffrey Medeiros,Keyur P. Patel	71
16	Sorafenib plus intensive chemotherapy improves survival in patients with newly diagnosed, FLT3‐internal tandem duplication mutation–positive acute myeloid leukemia 2019 ·Cancer ·Koji Sasaki,Hagop M. Kantarjian,Tapan M. Kadia,Keyur P. Patel,Sanam Loghavi,Guillermo Garcia‐Manero,Elias Jabbour,Courtney D. DiNardo,Naveen Pemmaraju,Naval Daver,Iman Abou Dalle,Nicholas J. Short,Musa Yılmaz,Prithviraj Bose,Kiran Naqvi,Sherry Pierce,Fevzi Yalniz,Jörge E. Cortes,Farhad Ravandi	36
17	Molecular Profile of Advanced Thyroid Carcinomas by Next-Generation Sequencing: Characterizing Tumors Beyond Diagnosis for Targeted Therapy 2018 ·Molecular Cancer Therapeutics ·Hui Chen,Rajyalakshmi Luthra,Mark J. Routbort,Keyur P. Patel,Maria E. Cabanillas,Russell R. Broaddus,Michelle D. Williams	70
18	Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition 2018 ·Cancer Research ·Jo Ishizawa,Kenji Nakamaru,Takahiko Seki,(unknown),Kensuke Kojima,Dhruv Chachad,Ran Zhao,Lauren Heese,Wencai Ma,Man Chun John,Courtney D. DiNardo,Sherry Pierce,Keyur P. Patel,Archie Tse,R. Eric Davis,Arvind Rao,Michael Andreeff	44
19	Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing 2015 ·Molecular Cancer Therapeutics ·Jeannelyn S. Estrella,Michael T. Tetzlaff,Roland L. Bassett,Keyur P. Patel,Michelle D. Williams,Jonathan L. Curry,Asif Rashid,Stanley R. Hamilton,Russell R. Broaddus	33
20	Hotspot Mutation Panel Testing Reveals Clonal Evolution in a Study of 265 Paired Primary and Metastatic Tumors 2015 ·Clinical Cancer Research ·Rashmi S. Goswami,Keyur P. Patel,Rajesh R. Singh,Funda Meric‐Bernstam,Scott Kopetz,Vivek Subbiah,Ricardo H. Álvarez,Michael A. Davies,Kausar J. Jabbar,Sinchita Roy‐Chowdhuri,Alexander J. Lazar,L. Jeffrey Medeiros,Russell R. Broaddus,Rajyalakshmi Luthra,Mark J. Routbort	59

About Keyur P. Patel

Keyur P. Patel is a scholar working on Hematology, Genetics and Cancer Research, having authored 334 papers that have together received 8.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (151 papers), Chronic Lymphocytic Leukemia Research (70 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (70 papers). The work is most often cited by research in Hematology (4.0k citations), Genetics (2.4k citations) and Cancer Research (2.0k citations). Keyur P. Patel has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include L. Jeffrey Medeiros, Hagop M. Kantarjian, Rajyalakshmi Luthra, Mark J. Routbort, Farhad Ravandi, Jörge E. Cortes, Guillermo Garcia‐Manero, Bedia A. Barkoh, Rashmi Kanagal‐Shamanna and Elias Jabbour. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact